Similar articles

• Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis - the SHARE initiative.

  Hočevar A, Ostrovršnik J, Tomšič M, Rotar Ž. Hočevar A, et al. Rheumatology (Oxford). 2019 Sep 1;58(9):1695-1697. doi: 10.1093/rheumatology/kez241. Rheumatology (Oxford). 2019. PMID: 31170291 No abstract available.
• Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.

  Oni L, Gritzfeld JF, Jones C, Sinha MD, Wallace D, Stack M, Kurt-Sukur ED, Quinlan C, Ruggiero B, Raja M, Tullus K. Oni L, et al. Rheumatology (Oxford). 2021 May 14;60(5):e179-e180. doi: 10.1093/rheumatology/keaa159. Rheumatology (Oxford). 2021. PMID: 32337557 No abstract available.
• Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.

  Jayne DR, Rasmussen N. Jayne DR, et al. Mayo Clin Proc. 1997 Aug;72(8):737-47. doi: 10.1016/S0025-6196(11)63594-5. Mayo Clin Proc. 1997. PMID: 9276602 Review.
• Classification and clinical diagnosis of cutaneous vasculitides.

  Fabbri P, Bonciani D, Antiga E, Caproni M. Fabbri P, et al. G Ital Dermatol Venereol. 2015 Apr;150(2):169-81. Epub 2015 Mar 17. G Ital Dermatol Venereol. 2015. PMID: 25776142 Review.
• Update on the European Vasculitis Study Group trials.

  Jayne D. Jayne D. Curr Opin Rheumatol. 2001 Jan;13(1):48-55. doi: 10.1097/00002281-200101000-00008. Curr Opin Rheumatol. 2001. PMID: 11148715 Review.